Parmax Pharma Ltd

NSE: PARMAX · BSE: 540359 · Pharmaceuticals & Biotechnology · 29 announcements

Share price: ₹139.10
Market cap: ₹52.04 Cr
Revenue (annual): ₹12.11 Cr
Net profit (annual): ₹-4.16 Cr
P/E (TTM): -43.5×Sector 47.4×
Promoter holding: 64.66%+33.86% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Capital Structure Change 6 Annual General Meeting 5 Open Offer 3 Financial Results 3 Other Announcement 2 Management Change 2 Board Meeting Date 2 Promoter Selling (Off-Market) 1 Promoter Reclassification 1 Promoter Buying 1 Fund Raise 1 Debt & Borrowing 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 17:50 IST BSE

Debt & Borrowing

Parmax Pharma Debt & Borrowing: ₹7.92 Cr

Parmax Pharma Ltd submitted its initial disclosure regarding the Large Corporate framework for the financial year. The company reported outstanding borrowings of ₹7.92 Crore and confirmed it does not meet the criteria to be classified as a Large Corporate under SEBI norms.

Value: ₹7.92 Cr

Read the filing ↗